Page last updated: 2024-09-04

vatalanib and Hypertension

vatalanib has been researched along with Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armand, JP; Mir, O; Ropert, S1
Abbas, F; André, T; de Gramont, A; Louvet, C; Tournigand, C1

Reviews

2 review(s) available for vatalanib and Hypertension

ArticleYear
[Oral drugs inhibiting the VEGF pathway].
    Bulletin du cancer, 2007, Volume: 94 Spec No

    Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Asthenia; Axitinib; Benzenesulfonates; Humans; Hypertension; Imidazoles; Indazoles; Indoles; Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Phthalazines; Piperidines; Proteinuria; Pyridines; Pyrroles; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib; Vascular Endothelial Growth Factor A

2007
[Anti-angiogenic treatment and colorectal cancer].
    Bulletin du cancer, 2007, Volume: 94 Spec No

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Humans; Hypertension; Intestinal Perforation; Neovascularization, Pathologic; Phthalazines; Pyridines; Thromboembolism; Vascular Endothelial Growth Factor A; Wound Healing

2007